<DOC>
	<DOCNO>NCT00876421</DOCNO>
	<brief_summary>The objective study investigate efficacy , safety tolerability ONO-8539 patient overactive bladder .</brief_summary>
	<brief_title>Study ONO-8539 Patients With Overactive Bladder</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Tolterodine Tartrate</mesh_term>
	<criteria>Patients medical history Overactive Bladder symptom &gt; 6 month Patients history presence significant disease , opinion investigator , might compromise patient 's safety evaluation study result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>ONO-8539</keyword>
	<keyword>Overactive bladder</keyword>
	<keyword>OAB</keyword>
</DOC>